Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

Clinical trial NCT05099471 · RECRUITING

Trial details

NCT number: NCT05099471
Sponsor: Christian Buske
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenstrom Macroglobulinemia Treatment Naive

Start date: 2025-03-21
Primary completion: 2028-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.